Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis.
González-de-Olano D, Alvarez-Twose I, Morgado JM, Esteban López MI, Vega Castro A, Díaz de Durana MD, Sánchez-Muñoz L, Matito A, de la Hoz Caballer B, Sanz ML, Orfao A, Escribano L. González-de-Olano D, et al. Among authors: escribano l. Cytometry B Clin Cytom. 2011 May;80(3):167-75. doi: 10.1002/cyto.b.20577. Epub 2010 Nov 10. Cytometry B Clin Cytom. 2011. PMID: 21520404 Free article.
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D, Alvarez-Twose I, Esteban-López MI, Sánchez-Muñoz L, de Durana MD, Vega A, García-Montero A, González-Mancebo E, Belver T, Herrero-Gil MD, Fernández-Rivas M, Orfao A, de la Hoz B, Castells MC, Escribano L. González de Olano D, et al. Among authors: escribano l. J Allergy Clin Immunol. 2008 Feb;121(2):519-26. doi: 10.1016/j.jaci.2007.11.010. Epub 2008 Jan 4. J Allergy Clin Immunol. 2008. PMID: 18177694
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, Sánchez-Muñoz L, Morgado JM, Perbellini O, García-Montero A, De Matteis G, Teodósio C, Rossini M, Jara-Acevedo M, Schena D, Mayado A, Zamò A, Mollejo M, Sánchez-López P, Cabañes N, Orfao A, Escribano L; Spanish Network on Mastocytosis (REMA); Italian Network on Mastocytosis (RIMA). Alvarez-Twose I, et al. Among authors: escribano l. J Allergy Clin Immunol. 2014 Feb;133(2):520-8. doi: 10.1016/j.jaci.2013.06.020. Epub 2013 Aug 6. J Allergy Clin Immunol. 2014. PMID: 23921094
Evaluation of the WHO criteria for the classification of patients with mastocytosis.
Sánchez-Muñoz L, Alvarez-Twose I, García-Montero AC, Teodosio C, Jara-Acevedo M, Pedreira CE, Matito A, Morgado JM, Sánchez ML, Mollejo M, Gonzalez-de-Olano D, Orfao A, Escribano L. Sánchez-Muñoz L, et al. Among authors: escribano l. Mod Pathol. 2011 Sep;24(9):1157-68. doi: 10.1038/modpathol.2011.84. Epub 2011 May 6. Mod Pathol. 2011. PMID: 21552214 Free article.
Dermoscopic features of skin lesions in patients with mastocytosis.
Vano-Galvan S, Alvarez-Twose I, De las Heras E, Morgado JM, Matito A, Sánchez-Muñoz L, Plana MN, Jaén P, Orfao A, Escribano L. Vano-Galvan S, et al. Among authors: escribano l. Arch Dermatol. 2011 Aug;147(8):932-40. doi: 10.1001/archdermatol.2011.190. Arch Dermatol. 2011. PMID: 21844452 Free article.
Childhood mastocytosis.
Torrelo A, Alvarez-Twose I, Escribano L. Torrelo A, et al. Among authors: escribano l. Curr Opin Pediatr. 2012 Aug;24(4):480-6. doi: 10.1097/MOP.0b013e328355b248. Curr Opin Pediatr. 2012. PMID: 22790101 Review.
Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.
Alvarez-Twose I, Bonadonna P, Matito A, Zanotti R, González-de-Olano D, Sánchez-Muñoz L, Morgado JM, Orfao A, Escribano L. Alvarez-Twose I, et al. Among authors: escribano l. J Allergy Clin Immunol. 2013 Feb;131(2):614-5. doi: 10.1016/j.jaci.2012.10.052. Epub 2012 Dec 28. J Allergy Clin Immunol. 2013. PMID: 23273956 Free article. No abstract available.
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.
Bonadonna P, Gonzalez-de-Olano D, Zanotti R, Riccio A, De Ferrari L, Lombardo C, Rogkakou A, Escribano L, Alvarez-Twose I, Matito A, Vega A, Passalacqua G. Bonadonna P, et al. Among authors: escribano l. J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):474-8. doi: 10.1016/j.jaip.2013.06.014. Epub 2013 Aug 30. J Allergy Clin Immunol Pract. 2013. PMID: 24565619 Clinical Trial.
171 results